7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2018-03-31 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2014-06-30 2014-03-31 2013-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2009-06-30 2009-03-31 
      
    		                                              
      operating activities:
    		                                              
      net income
    		174,380,000 157,003,000 150,922,000 154,852,000 146,501,000 145,499,000 135,690,000 102,551,000 155,651,000 162,118,000 177,653,000 191,174,000 169,760,000 119,114,000 99,102,000 101,021,000 107,975,000 118,068,000 116,015,000 88,270,000 95,056,000 93,072,000 54,753,000 103,681,000 111,836,000 121,602,000 106,480,000 85,553,000 84,941,000 80,284,000 71,479,000 68,779,000 66,470,000 61,188,000 60,444,000 58,062,000 61,033,000 54,507,000 55,686,000 51,928,000 54,995,000 52,900,000 47,818,000 44,699,000 37,859,000 44,982,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                              
      credit loss expense
    		6,779,000 13,129,000 13,070,000 16,162,000 19,386,000 15,787,000 13,650,000 15,981,000 11,185,000 9,901,000 9,104,000     0 0 0 63,000 13,756,000 20,302,000 31,975,000 175,197,000                        
      deferred tax expense
    		7,064,000 -2,728,000 -1,289,000 -435,000 -3,452,000 -3,267,000 -4,446,000 -11,782,000 -558,000 -680,000 -1,809,000 -1,540,000 -974,000 -1,972,000 -432,000 3,112,000 -516,000 1,016,000 4,172,000 -7,029,000 43,130,000 -25,844,000 -26,089,000 9,239,000 -950,000 -11,086,000 10,411,000 128,000 -4,301,000 -1,996,000 -5,238,000 -4,395,000 -2,607,000 -1,933,000 2,010,000 -1,438,000 -2,539,000 -382,000 384,000 -139,000 528,000 -1,013,000 -393,000 -1,290,000 -3,021,000 -2,181,000 
      accretion of loan discounts
    		-6,870,000 -5,830,000 -7,888,000 -7,686,000 -6,020,000 -5,279,000 -4,966,000 -4,650,000 -3,809,000 -4,140,000 -5,125,000 -2,349,000 -3,991,000 -3,636,000 -2,945,000 -3,011,000 -3,302,000 -3,152,000 -3,425,000 -3,787,000 -4,225,000 -3,620,000 -4,060,000 -3,833,000 -4,039,000 -3,947,000 -3,378,000 -3,490,000 -3,913,000 -3,708,000 -4,458,000 -3,727,000 -3,530,000 -3,503,000 -3,633,000 -2,701,000 -2,962,000 -4,092,000 -3,407,000 -2,366,000 -2,607,000 -2,595,000 -2,687,000 -2,655,000 -5,161,000 -3,314,000 
      securities premium amortization (discount accretion)
    		8,779,000 10,183,000 9,945,000 9,636,000 10,791,000 11,538,000 13,248,000 13,279,000 13,695,000 16,399,000 20,520,000 21,072,000 23,103,000 25,571,000 27,654,000 29,225,000 29,583,000 29,836,000 30,598,000 30,705,000 30,903,000 30,417,000 31,760,000 30,595,000 28,237,000 32,466,000 24,260,000 22,014,000 21,638,000 20,265,000 19,081,000 19,725,000 14,549,000 13,810,000 11,930,000 4,683,000 4,539,000 2,685,000 2,537,000 2,368,000 1,800,000 1,677,000 2,497,000 821,000 663,000 345,000 
      net (gain) loss on securities transactions
    		0 0 14,000 112,000    0 -12,000 -33,000 -21,000         0 0 0 -108,989,000 -28,000 -96,000 -188,000 19,000   37,000 0 -14,903,000   14,000 -370,000 491,000    0 -1,000 -5,000 0   
      depreciation and amortization
    		22,235,000 21,840,000 21,894,000 21,404,000 20,718,000 20,459,000 20,236,000 20,185,000 19,181,000 18,604,000 18,472,000 18,041,000 17,897,000 17,855,000 17,551,000 17,739,000 17,490,000 17,119,000 16,941,000 16,618,000 16,263,000 15,971,000 15,518,000 14,909,000 13,477,000 13,575,000 12,130,000 11,934,000 12,121,000 11,889,000 11,911,000 11,912,000 9,755,000 9,702,000 9,754,000 9,445,000 9,497,000 9,582,000 9,309,000 9,191,000 9,674,000 9,285,000 8,970,000 9,235,000 9,047,000 8,817,000 
      net (gain) loss on sale/write-down of assets/foreclosed assets
    		80,000 -11,000 -2,363,000  -453,000 19,000 91,000  89,000 1,000 -284,000  6,000 -27,000 130,000  -9,000 -1,742,000 -134,000 530,000 133,000 -536,000 397,000 304,000 -881,000 -1,153,000 -3,982,000 -850,000 -533,000 223,000 36,000 -632,000 792,000 147,000             
      stock-based compensation
    		4,270,000 4,832,000 4,081,000 9,743,000 1,759,000 4,523,000 3,738,000 11,944,000 3,111,000 4,793,000 4,742,000 9,619,000 3,173,000 3,418,000 2,112,000 4,997,000 1,985,000 3,245,000 2,526,000 5,691,000 2,443,000 3,272,000 2,512,000 5,253,000 2,675,000 4,843,000 3,175,000 3,188,000 3,103,000 2,521,000 2,995,000 2,482,000 2,560,000 2,136,000 2,325,000 2,843,000 2,555,000 2,433,000 3,846,000 3,737,000       
      net tax benefit from stock-based compensation
    		440,000 464,000 912,000 2,515,000 659,000 248,000 373,000 311,000 114,000 127,000 342,000 1,708,000 1,249,000 401,000 1,244,000 3,372,000 287,000 1,082,000 3,136,000 158,000 138,000 220,000 336,000 845,000 471,000 -1,080,000 2,211,000 2,064,000 3,515,000                  
      earnings on life insurance policies
    		-1,026,000 -954,000 -928,000 -960,000 -945,000 -931,000 -909,000 -780,000 -777,000 -762,000 -625,000 -535,000 -545,000 -483,000 -533,000 -561,000 -558,000 -603,000 -740,000 -836,000 -960,000 -1,013,000 -922,000 -939,000 -914,000 -1,010,000 -820,000 -782,000 -783,000 -933,000 -878,000 -867,000 -732,000 -682,000 -700,000 -1,006,000 -1,068,000 -1,016,000 -973,000 -988,000 -1,179,000 -1,078,000 -1,096,000 -1,118,000 -1,332,000 -1,273,000 
      net change in:
    		                                              
      trading account securities
    		1,973,000 -3,557,000 -752,000 -3,024,000 -445,000 3,383,000 -3,558,000 -1,200,000 -1,355,000 -1,404,000 1,739,000 -870,000 -328,000 343,000 139,000 -139,000 -740,000 2,472,000 -2,153,000 39,000 0 12,622,000 -12,819,000 2,920,000 -2,064,000 -2,394,000 1,326,000 -6,032,000 -1,088,000 241,000 621,000 -444,000 0 909,000 1,488,000 283,000 -3,237,000 -1,306,000 6,229,000 -5,645,000 899,000 778,000 -485,000 600,000 732,000 -1,694,000 
      lease right-of-use assets
    		5,340,000 6,497,000 6,390,000 6,373,000 6,418,000 6,253,000 6,220,000 6,226,000 6,154,000 6,241,000 4,952,000 6,258,000 6,109,000 6,072,000 5,970,000 5,938,000 5,869,000 5,808,000 5,889,000 6,514,000 5,928,000 5,871,000 5,620,000 5,506,000 5,451,000                      
      accrued interest receivable and other assets
    		67,732,000 -54,181,000 55,711,000 -63,503,000 35,036,000 -44,156,000 331,765,000 -288,105,000 -3,611,000 -73,294,000 132,345,000 -52,861,000 71,857,000 -80,007,000 -55,232,000 19,289,000 -26,654,000 -112,359,000 73,164,000 -105,422,000 78,930,000 -50,672,000 -81,100,000 -53,178,000 55,715,000 -41,662,000 23,555,000 -75,821,000 55,705,000 37,929,000 -56,213,000 29,418,000 -49,570,000 14,633,000 54,017,000 -18,508,000 41,769,000 9,843,000 4,124,000 27,621,000 18,995,000 -31,947,000 10,488,000 10,375,000 -9,514,000 77,238,000 
      accrued interest payable and other liabilities
    		-42,593,000 -5,915,000 -545,830,000 -81,089,000 77,280,000 -24,497,000 -22,698,000 52,095,000 39,630,000 16,941,000 -193,659,000 -10,047,000 -42,458,000 -124,420,000 238,065,000 -75,540,000 72,613,000 68,035,000 -26,287,000 3,938,000 -19,903,000 -153,703,000 196,814,000 -74,735,000 76,362,000 -48,384,000 28,376,000 12,425,000 -48,702,000 1,668,000 1,240,000 -5,714,000 -14,666,000 -29,098,000 -7,312,000 9,883,000 -9,286,000 16,903,000 7,245,000 -25,293,000 27,219,000 12,773,000 -4,067,000 5,203,000 340,000 -63,953,000 
      net cash from operating activities
    		248,583,000 140,772,000 -296,111,000 64,302,000 307,217,000 129,579,000 488,434,000 -83,001,000 238,688,000 154,812,000 168,346,000 182,670,000 244,858,000 -37,771,000 332,825,000 95,680,000 204,023,000 128,825,000 219,765,000 49,145,000 268,138,000 -41,968,000 248,928,000 48,894,000 293,281,000 81,207,000 210,708,000 58,807,000 129,655,000 155,260,000 49,624,000 130,090,000 27,629,000 72,583,000 133,557,000 65,545,000 101,910,000 93,669,000 94,434,000 71,237,000 124,919,000 72,601,000 85,186,000 90,334,000 51,414,000 71,809,000 
      investing activities:
    		                                              
      securities held to maturity:
    		                                              
      purchases
    		0 0 -1,500,000     0 -6,181,000 -301,649,000 -839,794,000 -545,671,000 -466,907,000 -379,982,000 -31,545,000     0 0 0 -1,500,000    -1,500,000     -813,955,000   -36,464,000   -16,496,000 -9,141,000 -57,547,000 -3,833,000 6,821,845,000 -7,068,993,000 -266,386,000 -10,750,936,000 -599,011,000 
      maturities, calls and principal repayments
    		30,613,000 24,103,000 22,785,000 34,993,000 15,432,000 13,633,000 17,692,000 7,677,000 61,918,000 25,236,000 67,311,000 3,487,000 294,675,000 152,015,000 111,211,000 5,624,000 49,553,000 2,387,000 120,029,000 244,000 12,101,000 9,706,000 41,526,000 12,489,000 9,196,000 -119,072,000 179,149,000 35,417,000 599,457,000 63,073,000 15,180,000 149,507,000 1,158,000 42,113,000 3,838,000 174,000 315,000 163,000 145,000 156,000 188,000 163,000 190,000 232,000 172,000 193,000 
      securities available for sale:
    		                                              
      sales
    		2,651,000 0 38,556,000 62,663,000    0 360,712,000 659,082,000 884,273,000         0 0 51,250,000 1,111,102,000 10,424,081,000 4,944,537,000     0 0 135,610,000   1,474,000 6,002,402,000 9,985,078,000 39,005,000 845,000 5,547,541,000 0 2,999,251,000 6,998,743,000 0   
      proceeds from sale of loans
    		6,814,000 6,700,000 605,000 2,132,000 0 891,000 300,000 13,636,000 0   0 0           0 0     0                 
      net change in loans
    		-198,271,000 -362,596,000 -151,515,000 -721,225,000 -65,360,000 -612,888,000 -566,638,000 -444,862,000 -654,131,000 -268,194,000 -334,708,000 -206,040,000 -213,466,000 -195,025,000 -209,490,000 -503,505,000 764,630,000 1,291,635,000 -406,836,000 695,255,000 -258,031,000 -2,671,105,000 -622,514,000 -124,364,000 -178,771,000 -163,035,000 -227,417,000 -335,127,000 -214,281,000 1,494,000 -89,560,000 -54,632,000 -253,620,000 -237,216,000 -75,749,000 -367,863,000 -133,759,000 -36,766,000 -56,409,000 75,427,000 5,291,000 105,136,000 158,517,000 97,184,000 120,977,000 59,764,000 
      net cash paid in insurance agency asset acquisition
    		                                              
      benefits received on life insurance policies
    		-43,000 1,133,000 687,000 760,000 0 934,000 129,000 937,000 0 788,000 212,000 715,000 0 131,000 1,201,000 363,000 435,000 541,000 968,000 0        1,000 461,000 315,000              427,000 112,000 111,000 
      proceeds from sales of premises and equipment
    		6,000 33,000 5,000 8,000 8,000 5,000 4,000 0 103,000 3,000 1,176,000 16,000 29,000 17,000 1,000 11,000 597,000 6,433,000 3,000 2,934,000 0 3,053,000 1,000 19,000 3,342,000 -6,640,000 11,317,000 6,000 1,544,000 1,000 3,000 1,513,000 13,000 15,000 11,000 3,399,000 214,000 125,000 143,000 988,000 178,000 150,000 577,000 64,000 5,000 1,000 
      purchases of premises and equipment
    		-36,918,000 -26,265,000 -40,953,000 -37,647,000 -25,329,000 -26,616,000 -38,184,000 -40,568,000 -32,906,000 -39,053,000 -46,103,000 -46,866,000 -27,619,000 -15,642,000 -12,374,000 -28,762,000 -9,035,000 -15,239,000 -12,814,000 -13,556,000 -29,830,000 -20,287,000 -31,749,000 -38,390,000 -69,704,000 -81,863,000 -16,759,000 -8,170,000 -6,311,000 -9,188,000 -16,093,000 -7,366,000 -31,403,000 -13,215,000 -6,263,000 -7,756,000 -8,276,000 -10,994,000 -8,686,000 -3,586,000 -3,019,000 -1,907,000 -4,440,000 -23,132,000 -15,367,000 -23,959,000 
      proceeds from sales of foreclosed assets
    		0 0 15,135,000                                            
      net cash from investing activities
    		-275,187,000 -57,571,000 -1,818,642,000 -294,407,000 179,117,000 -686,090,000 620,501,000 -111,925,000 -112,193,000 -69,345,000 -649,288,000 -1,727,930,000 -1,577,503,000 -1,712,197,000 -3,259,700,000 -3,339,812,000 51,994,000 1,164,832,000 -402,029,000 936,582,000 -489,430,000 -2,469,196,000 390,997,000 -178,573,000 -252,252,000 -702,734,000 -253,191,000 -363,379,000 22,797,000 -424,441,000 -685,587,000 562,923,000 -28,606,000 339,483,000 346,776,000 -258,232,000 -925,277,000 107,453,000 240,312,000 -479,796,000 -457,731,000 -133,534,000 342,375,000 -20,916,000 -220,862,000 -384,070,000 
      financing activities:
    		                                              
      net change in deposits
    		833,538,000 -707,057,000 -332,077,000 1,002,127,000 1,402,481,000 -488,346,000 -1,114,082,000 928,333,000 291,405,000 -1,483,325,000 -1,770,041,000 -2,605,990,000 958,421,000 1,170,836,000 1,735,233,000 3,082,929,000 878,627,000 1,808,960,000 1,909,419,000 1,516,258,000 820,407,000 4,538,229,000 501,303,000 555,982,000 1,098,559,000 -969,570,000 -194,611,000 -528,591,000 330,589,000 820,097,000 130,476,000 -186,620,000 -173,070,000 376,847,000 900,675,000 368,096,000 152,273,000 959,742,000 394,572,000 230,217,000 577,927,000 218,412,000 420,438,000 425,001,000 463,606,000 524,194,000 
      net change in short-term borrowings
    		151,445,000 -49,041,000 128,204,000 328,504,000 237,545,000 -185,540,000 -156,981,000 393,193,000 164,800,000 -711,499,000 -417,397,000 2,603,352,000 401,054,000 -169,933,000 -888,906,000 539,495,000 -16,360,000 320,165,000 -193,573,000 508,330,000 19,283,000 418,406,000 -524,364,000 494,687,000 -118,852,000 67,562,000 -115,603,000 29,667,000 -81,792,000 71,142,000 39,274,000 -199,636,000 47,567,000 -153,018,000 37,314,000 18,927,000 -85,104,000 84,114,000 20,561,000 77,898,000 -7,759,000 -42,957,000 -595,000 -203,442,000 21,888,000 -438,804,000 
      proceeds from stock option exercises
    		1,925,000 2,248,000 3,708,000 7,159,000 10,275,000 2,294,000 2,915,000 6,257,000 596,000 946,000 1,500,000 4,899,000 5,270,000 751,000 5,739,000 16,607,000 1,128,000 7,285,000 29,397,000 5,013,000 2,698,000 3,383,000 1,463,000 7,264,000 5,665,000 -11,324,000 19,165,000 19,402,000 24,747,000 44,287,000 3,490,000 96,000 2,830,000 17,279,000 30,837,000 1,669,000 5,542,000 0 1,470,000 5,769,000 5,358,000 7,307,000 15,865,000 7,920,000 7,720,000 215,000 
      purchase of treasury stock
    		-69,785,000 -76,000 -2,600,000 -8,628,000 -20,047,000 -30,153,000 -2,073,000 -2,224,000 -11,372,000 -27,951,000 -1,173,000 -3,395,000 0 0 -996,000 -2,522,000 -54,000 0 -1,288,000 -1,785,000 -27,000 0 -13,973,000 -1,084,000 -17,190,000   0 -42,000      -28,800,000   0 -1,456,000 -201,000 0 0 -193,000    
      cash dividends paid on preferred stock
    		-1,668,000 -1,669,000 -1,669,000 -1,669,000 -1,668,000 -1,669,000 -1,669,000 -1,669,000 -1,668,000 -1,669,000 -1,669,000 -1,669,000 -1,668,000 -1,669,000 -1,669,000 -1,669,000 -1,668,000 -1,669,000 -2,151,000 0 0 0 -2,016,000 -2,016,000 -2,016,000 -2,015,000 -2,016,000 -2,015,000 -2,016,000 -2,016,000 -2,015,000 -2,016,000 -2,015,000 -2,016,000 -2,015,000            
      cash dividends paid on common stock
    		-64,702,000 -64,927,000 -61,663,000 -61,504,000 -61,330,000 -59,808,000 -59,804,000 -59,771,000 -59,509,000 -56,407,000 -56,636,000 -56,503,000 -56,319,000 -48,515,000 -48,443,000 -48,276,000 -48,114,000 -46,272,000 -46,124,000 -45,822,000 -44,957,000 -44,871,000 -44,934,000 -44,874,000 -44,704,000 -50,877,000 -36,551,000 -36,737,000 -34,656,000 -34,039,000 -33,586,000 -32,938,000 -32,173,000 -30,487,000 -30,313,000            
      net cash from financing activities
    		850,753,000 -820,522,000 -266,097,000 1,265,989,000 1,567,256,000 -763,222,000 -1,331,694,000 1,264,119,000 384,252,000 -2,279,905,000 -2,245,416,000 -59,306,000 1,306,758,000 951,470,000 800,958,000 3,573,161,000 813,559,000 2,088,469,000 1,695,680,000 2,127,446,000 797,404,000 4,915,147,000 -232,521,000 1,009,959,000 921,462,000 -1,016,743,000 -329,616,000 -518,286,000 235,276,000 899,346,000 137,723,000 -421,073,000 -156,544,000 209,940,000 938,373,000 359,204,000 44,509,000 865,678,000 387,144,000 286,253,000 536,883,000 150,009,000 410,697,000 205,000,000 468,542,000 290,709,000 
      net change in cash and cash equivalents
    		824,149,000 -737,321,000 -2,380,850,000 1,035,884,000 2,053,590,000 -1,319,733,000 -222,759,000 1,069,193,000 510,747,000 -2,194,438,000 -2,726,358,000 -1,604,566,000 -25,887,000 -798,498,000 -2,125,917,000 329,029,000 1,069,576,000 3,382,126,000 1,513,416,000 3,113,173,000 576,112,000 2,403,983,000 407,404,000 880,280,000 962,491,000 -1,638,270,000 -372,099,000 -822,858,000 387,728,000 630,165,000 -498,240,000 271,940,000 -157,521,000 622,006,000 1,418,706,000 166,517,000 -778,858,000 1,066,800,000 721,890,000 -122,306,000 204,071,000 89,076,000 838,258,000 274,418,000 299,094,000 -21,552,000 
      cash and cash equivalents at beginning of period
    		0 0 10,234,258,000  0 0 8,687,276,000  0 0 12,028,132,000  0 0 16,583,000,000  0 0 10,288,853,000  0 0 3,788,181,000  0 -1,097,268,000 5,053,047,000                    
      cash and cash equivalents at end of period
    		824,149,000 -737,321,000 7,853,408,000  2,053,590,000 -1,319,733,000 8,464,517,000  510,747,000 -2,194,438,000 9,301,774,000  -25,887,000 -798,498,000 14,457,083,000  1,069,576,000 3,382,126,000 11,802,269,000  576,112,000 2,403,983,000 4,195,585,000  962,491,000 -2,735,538,000 4,680,948,000                    
      net (gain) loss on sale/exchange/write-down of assets/foreclosed assets
    		                                              
      net cash paid in insurance agency asset acquisitions
    		                                              
      proceeds from sales of repossessed properties
    		   17,000    0 0 25,000 558,000 0 1,042,000 0 1,543,000 0 709,000 0 100,000 0 65,000 0 8,000 532,000 126,000 -302,000 307,000 0 345,000 0 240,000 57,000 1,691,000 1,719,000 2,282,000 5,008,000 4,522,000 2,949,000 5,277,000 3,599,000 1,159,000 -4,887,000 8,235,000 1,687,000 1,311,000 2,321,000 
      cash and cash equivalents at beginning of year
    		                                              
      cash and cash equivalents at end of year
    		                                              
      principal payments on long-term borrowings
    		                                  0 -5,000 -4,000 -150,005,000 -4,000 -5,000 -12,377,000 -6,504,000 -4,000 -5,000 -4,000 -2,000 
      proceeds from federal home loan bank advances
    		                   0 0                          
      principal payments on federal home loan bank advances
    		                   0 0                          
      redemption of series a preferred stock
    		                                              
      proceeds from issuance of series b preferred stock
    		                                              
      redemption of preferred stock
    		                    0 0 -150,000,000                        
      benefit from loan losses
    		                       8,355,000 8,001,000 10,458,000 6,945,000 8,426,000 7,952,000 5,045,000 9,189,000 28,500,000 4,924,000 6,600,000 5,108,000 2,355,000 1,100,000 9,010,000         
      proceeds from issuance of subordinated notes
    		                           -12,000 98,446,000                  
      principal payments on subordinated notes
    		                           0 -100,000,000                  
      cash and equivalents at beginning of period
    		                           0 4,141,445,000 0 0 3,591,523,000 0 4,556,125,000 0 0 2,907,592,000 0 0 2,820,977,000 0 0 1,721,479,000 0 0 1,237,331,000 
      cash and equivalents at end of period
    		                           -822,858,000 4,529,173,000 630,165,000 -498,240,000 3,863,463,000 -157,521,000 5,178,131,000 1,418,706,000 166,517,000 2,128,734,000 1,066,800,000 721,890,000 2,698,671,000 204,071,000 89,076,000 2,559,737,000 274,418,000 299,094,000 1,215,779,000 
      net excess tax benefit from stock-based compensation
    		                                              
      tax deficiency from stock-based compensation
    		                                              
      excess tax benefits from stock-based compensation
    		                              -84,000 -41,000 -317,000 -1,335,000 -1,875,000 -35,000 -41,000 -26,000 -213,000 -154,000 -194,000 -160,000 -259,000 -413,000 -153,000 -64,000 
      net tax benefit (deficiency) from stock-based compensation
    		                               -3,000 3,000 9,000 52,000 -72,000 -418,000 0 -24,000 -65,000 -7,000 73,000 -215,000    
      net cash (paid) received in acquisitions
    		                                              
      proceeds from issuance of preferred stock
    		                                  0            
      accelerated share repurchase forward contract
    		                                              
      net cash paid in acquisitions
    		                                   0 -7,199,000 0      -455,000 0 -750,000 
      net income on sale/write-down of assets/foreclosed assets
    		                                  -65,000 2,121,000 477,000          
      accelerated stock repurchase agreement
    		                                              
      cash dividends paid
    		                                   -29,518,000 -28,239,000 -28,199,000 -28,212,000 -27,579,000 -27,358,000 -27,288,000 -25,922,000 -25,722,000 -25,642,000 -24,958,000 
      net gain on securities transactions
    		                                     -6,409,000 0 -5,000       
      net (gain) loss on sale of loans held for sale and other assets
    		                                     1,937,000   1,274,000 1,357,000 1,864,000 1,661,000 -222,000 256,000 
      student loans held for sale
    		                                           2,781,000   
      common stock/treasury stock sold to the 401(k) stock purchase plan
    		                                        898,000 879,000 849,000    
      benefit from possible loan losses
    		                                       9,450,000 10,100,000 8,650,000 13,571,000 16,940,000 16,601,000 9,601,000 
      net income on sale of loans held for sale and other assets
    		                                       1,597,000       
      stock-based compensation expense
    		                                        3,422,000 3,410,000 3,648,000 3,083,000 3,381,000 3,024,000 
      loans held for sale
    		                                        0 18,492,000 5,537,000    
      proceeds from long-term borrowings
    		                                           0 0 230,000,000 
      tax benefits from stock-based compensation
    		                                           412,000 383,000 6,000 
      excess tax benefits from stock-based compensation arrangements
    		                                           413,000 153,000 64,000 
      treasury stock sold to the 401(k) stock purchase plan
    		                                           835,000   
      origination of loans held for sale
    		                                             -12,000 
      proceeds from sales of loans held for sale
    		                                             31,000 
      supplemental disclosures:
    		                                              
      cash paid for interest
    		                                             29,748,000 
      cash paid for income taxes
    		                                             38,000 
      net gain on sale of loans held for sale and other assets
    		                                              
      tax benefit from stock-based compensation
    		                                              
      proceeds from notes payable
    		                                              
      principal payments on notes payable and other borrowings
    		                                              
      origination of loans held for sale, net of principal collected
    		                                              
      net proceeds from settlement of legal claims
    		                                              
      proceeds from junior subordinated deferrable interest debentures
    		                                              
      tax benefit from stock option exercises
    		                                              
      amortization of deferred compensation
    		                                              
      charge for discontinued operations
    		                                              
      deferred tax benefit
    		                                              
      net gain on sale of assets
    		                                              
      net cash paid (received) in acquisitions
    		                                              
      purchase of life insurance policies
    		                                              
      return of capital on life insurance policies
    		                                              
      net proceeds from issuance of subordinated notes
    		                                              
      repurchase of restricted stock
    		                                              
      operating activities
    		                                              
      credit for deferred taxes
    		                                              
      accretion of discounts on loans
    		                                              
      accretion of securities’ discounts
    		                                              
      amortization of securities’ premiums
    		                                              
      increase in trading account securities
    		                                              
      net realized gain on securities transactions
    		                                              
      increase in interest payable
    		                                              
      originations of loans held-for-sale
    		                                              
      proceeds from sales of loans held-for-sale
    		                                              
      tax benefit from exercise of employee stock options
    		                                              
      discontinued operations non-cash charges
    		                                              
      net change in other assets and liabilities
    		                                              
      investing activities
    		                                              
      proceeds from maturities of securities held to maturity
    		                                              
      purchases of investment securities held to maturity
    		                                              
      proceeds from sales of securities available for sale
    		                                              
      proceeds from maturities of securities available for sale
    		                                              
      purchases of securities available for sale
    		                                              
      purchase of bank-owned life insurance
    		                                              
      increase in value of bank-owned life insurance, net of return of capital
    		                                              
      net increase in loan portfolio
    		                                              
      net inflow(outflow) from acquisitions
    		                                              
      net increase in premises and equipment
    		                                              
      net cash used by investing activities
    		                                              
      financing activities
    		                                              
      net increase in demand deposits, ioc accounts, savings accounts and public funds
    		                                              
      net increase in certificates of deposit
    		                                              
      net increase(decrease) in short-term borrowings
    		                                              
      proceeds from employee stock purchase plan and options
    		                                              
      dividends paid
    		                                              
      increase in cash and cash equivalents
    		                                              
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.